PDSB
PDS Biotechnology Corporation Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
PDS Biotechnology (PDSB) Stock: Buy, Sell, or Hold?
$1.02
-0.01 (-0.97%)
▼
5d:
-21.54%
30d:
-36.25%
90d:
+337.39%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$1.04 – $1.42
Position: OVERSOLD
Forward P/E & Valuation
-5.4x
Next 12M consensus est.
Wall Street Target
$4.50
+341.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.94 / $1.70
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: PDSB is down 21.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When PDSB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PDSB is currently trading at $1.02, which is considered oversold relative to its 30-day fair value range of $1.04 to $1.42.
Technical Outlook: Technically, PDSB is in a strong downtrend. Immediate support is located at $0.94, while resistance sits at $1.70.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.50 (+341.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PDSB is in a strong downtrend. Immediate support is located at $0.94, while resistance sits at $1.70.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.50 (+341.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.04 -
$1.42
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$1.04 -
$1.42
Current vs Trading Range
OVERSOLD
Support Level
$0.94
Resistance Level
$1.70
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 341.2% below Wall St target ($4.50)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.37
Wall Street Target
$4.50
(+341.2%)
Share PDSB Analysis
Share this live PDSB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PDSB)
Bullish
6 Retail Mentions
Reddit / WSB Comments
3
Bullish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
PDS Biotech announces exercise of warrants by NantWorks for approximately $3.9 million, with the proceeds to be used for advancing PDS0301 toward a Phase 3 trial and general corporate purposes.
Key Retail Themes:
Company's focus on developing targeted immunotherapies for cancer
Advancement of PDS0301 towards a Phase 3 trial
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:24 PM ET
Data refreshes hourly during market hours. Next update: 10:24 PM
Data refreshes hourly during market hours. Next update: 10:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PDSB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PDSB Research Pages
